Pages that link to "Q35757157"

The following pages link to Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis (Q35757157):

Displaying 25 items.

• Chemokines and Chemokine Receptors in the Development of Lupus Nephritis (Q26741199) (← links)
• Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections (Q33367767) (← links)
• Effect of interleukin 6 deficiency on renal interstitial fibrosis (Q34526130) (← links)
• Absence of nicotinic acetylcholine receptor α7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model (Q35879006) (← links)
• Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN. (Q36426118) (← links)
• Leukocytes in glomerular injury (Q36972471) (← links)
• CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein (Q37197326) (← links)
• Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration (Q37462622) (← links)
• Increased serum CXCL16 is highly correlated with blood lipids, urine protein and immune reaction in children with active nephrotic syndrome (Q37561173) (← links)
• Critical role of CXCL16 in hypertensive kidney injury and fibrosis (Q37587848) (← links)
• The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity (Q37828761) (← links)
• Targeting chemokines in proteinuria-induced renal disease (Q38026076) (← links)
• Role of chemokines in proteinuric kidney disorders (Q38188747) (← links)
• TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation (Q39406226) (← links)
• CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis (Q42356972) (← links)
• CXCL16: a chemokine-causing chronic kidney disease (Q42385774) (← links)
• Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy (Q43064999) (← links)
• Effect of Simvastatin on Lipid Accumulation and the Expression of CXCL16 and Nephrin in Podocyte Induced by Oxidized LDL. (Q50204509) (← links)
• Natural killer cell memory (Q51000689) (← links)
• Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis (Q57176120) (← links)
• Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney (Q58323008) (← links)
• Adenosine A2A receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation (Q83917871) (← links)
• Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations (Q87386979) (← links)
• Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk (Q89810882) (← links)
• Plasma chemokine CXC motif-ligand 16 as a predictor of renal prognosis in immunoglobulin A nephropathy (Q94476056) (← links)